Ranbaxy Laboratories swung to a profit for the quarter ended June 2014. During the quarter, the company reported a profit of Rs 7,551.23 million compared with a loss of Rs 6,088.09 million in the same quarter last year.
Net sales for the quarter surged 51.41% to Rs 21,786.25 million, compared with Rs 14,389 million for the prior year period.
Earnings per share stood at Rs 17.80 compared with negative Rs 14.40 in the same quarter last year.
Quarterly Results - Standalone (Rs in mn) |
As at | Jun - 14 | Jun - 13 | %Change |
Net Sales | 21,786.25 | 14,388.86 | 51.41 |
Net Profit | 7,551.23 | (6,088.09) | - |
Basic EPS | 17.80 | (14.40) | - |
Shares of the company gained Rs 7.2, or 1.24%, to settle at Rs 590.00. The total volume of shares traded was 103,182 at the BSE (Monday).